[go: up one dir, main page]

WO2004096119A3 - Topical pharmaceutical compositions, methods of manufacture thereof and articles of manufacture containing same - Google Patents

Topical pharmaceutical compositions, methods of manufacture thereof and articles of manufacture containing same Download PDF

Info

Publication number
WO2004096119A3
WO2004096119A3 PCT/IL2004/000350 IL2004000350W WO2004096119A3 WO 2004096119 A3 WO2004096119 A3 WO 2004096119A3 IL 2004000350 W IL2004000350 W IL 2004000350W WO 2004096119 A3 WO2004096119 A3 WO 2004096119A3
Authority
WO
WIPO (PCT)
Prior art keywords
manufacture
articles
methods
pharmaceutical compositions
containing same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IL2004/000350
Other languages
French (fr)
Other versions
WO2004096119A2 (en
Inventor
Shaul Eger
Isaac Neeman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Eger Olive Oil Products Industry Ltd
Original Assignee
Dr Eger Olive Oil Products Industry Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Eger Olive Oil Products Industry Ltd filed Critical Dr Eger Olive Oil Products Industry Ltd
Publication of WO2004096119A2 publication Critical patent/WO2004096119A2/en
Publication of WO2004096119A3 publication Critical patent/WO2004096119A3/en
Anticipated expiration legal-status Critical
Priority to US11/261,640 priority Critical patent/US7201927B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

A healing composition, in particular being a cream, with a broad-spectrum sanative effect, substantially comprising a mixture of a monounsaturated fatty acid and an omega-3 fatty acid, is disclosed. In a preferable embodiment the composition includes antioxidants.
PCT/IL2004/000350 2003-04-30 2004-04-25 Topical pharmaceutical compositions, methods of manufacture thereof and articles of manufacture containing same Ceased WO2004096119A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/261,640 US7201927B2 (en) 2004-04-25 2005-10-31 Nutritional olive oil based compositions, and method of consumption thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46640903P 2003-04-30 2003-04-30
US60/466,409 2003-04-30

Publications (2)

Publication Number Publication Date
WO2004096119A2 WO2004096119A2 (en) 2004-11-11
WO2004096119A3 true WO2004096119A3 (en) 2005-06-30

Family

ID=33418375

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2004/000350 Ceased WO2004096119A2 (en) 2003-04-30 2004-04-25 Topical pharmaceutical compositions, methods of manufacture thereof and articles of manufacture containing same

Country Status (1)

Country Link
WO (1) WO2004096119A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2274721B1 (en) * 2005-11-03 2008-06-01 Laboratorios Belmac, S.A. NEW THERAPEUTIC AGENT FOR THE TREATMENT OF A CONDITION ASSOCIATED WITH PERIPHERAL VASCULAR DISEASE.
EP2279667A1 (en) 2009-07-30 2011-02-02 Brudy Technology, S.L. Vegetable and marine oil or fat compositions enriched with DHA or EPA and C18 or higher fatty acid
EP2570124B1 (en) * 2010-05-14 2016-11-02 Sanidad Y Residencias 21, S.A. Oleuropein compositions for healing wounds and ulcers in elderly people and/or diabetics
AU2011320994B2 (en) * 2010-10-27 2016-08-25 Nestec S.A. Methods and compositions suitable for promoting healthy skin
ES2395539B1 (en) * 2011-06-16 2014-01-20 Agencia Pública Empresarial Sanitaria Hospital Alto Guadalquivir Use of olive oil in the prevention and treatment of diseases that occur with an ischemic process

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6078542A (en) * 1983-10-03 1985-05-04 Nikken Sutamii Kk Production of food oil having balanced fatty acid content

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6078542A (en) * 1983-10-03 1985-05-04 Nikken Sutamii Kk Production of food oil having balanced fatty acid content

Also Published As

Publication number Publication date
WO2004096119A2 (en) 2004-11-11

Similar Documents

Publication Publication Date Title
EP2218342A3 (en) Novel nutraceutical compositions and use thereof
HUP0303347A3 (en) Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis polymorphonucleate and mononucleate cells, process for their preparation and pharmaceutical compositions containing them
WO2008063910A3 (en) Method of preparing solid dosage forms of multi-phasic pharmaceutical compositions
AU2003239609A1 (en) 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
MXPA05009933A (en) Compositions comprising fatty acids and amino acids.
AU2003244632A1 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
WO2002006213A3 (en) Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
WO2006024490A3 (en) Methods and compositions for the treatment of cell proliferation
WO2008010963A3 (en) Immune response modifier formulations
WO2003013497A1 (en) Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction
WO2009055568A3 (en) Liposomal vancomycin formulations
IL173726A (en) Pharmaceutical compositions comprising n-n-dihaloamino acid and uses thereof
WO2002064129A3 (en) Compositions of biochemical compounds involved in bioenergy metabolism of cells
IL164089A0 (en) Astaxanthin medium-chain fatty acidester, production method of the same, and composition comprising the same
WO2004095946A3 (en) Medical food tablets containing free amino acids
WO2005065650A3 (en) Aerosol formulations comprising a carboxylic acid surfactant
WO2004091591A3 (en) Nutritional or therapeutic composition containing the compound oleuropeine or one of the derivatives thereof
WO2003066597A3 (en) Guanidino compounds
AU2003228937A1 (en) Preparation of yogurt containing confectionery pieces and product thereof
WO2004096119A3 (en) Topical pharmaceutical compositions, methods of manufacture thereof and articles of manufacture containing same
AU2002341555A1 (en) Levothyroxine pharmaceutical compositions, methods of making and methods of administration
IL174336A0 (en) Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
WO2005053660A3 (en) Pharmaceutical compositions comprising danazol
WO2006109194A3 (en) Chromium-fatty acid compounds and methods of making and using thereof
WO2000059448A3 (en) Association of no-synthase inhibitor(s) and metabolic antioxidant(s)

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 11261640

Country of ref document: US

122 Ep: pct application non-entry in european phase